Tim G. Brooks

Porton, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 238 publications

Development of a live-attenuated vaccine challenge model of Yersinia pestis in humans: Expert consultation on clinical trial considerations, January 2025.

Development of a live-attenuated vaccine challenge model of Yersinia pestis in humans: Expert consultation on clinical trial considerations, January 2025.

Journal: Vaccine

Published: March 27, 2025

Tick-borne encephalitis: from tick surveillance to the first confirmed human cases, the United Kingdom, 2015 to 2023.

Tick-borne encephalitis: from tick surveillance to the first confirmed human cases, the United Kingdom, 2015 to 2023.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: February 07, 2025

Investigation of a Human Case of Francisella tularensis Infection, United Kingdom, 2023.

Investigation of a Human Case of Francisella tularensis Infection, United Kingdom, 2023.

Journal: Emerging infectious diseases

Published: September 25, 2024

Persistent cluster of NDM-1 carbapenemase-producing Klebsiella pneumoniae among patients attending a haematology ward in England.

Persistent cluster of NDM-1 carbapenemase-producing Klebsiella pneumoniae among patients attending a haematology ward in England.

Journal: The Journal of hospital infection

Published: September 11, 2024

Seroprevalence of Borrelia burgdorferi sensu lato antibodies in English adult blood donors: A nationwide cross-sectional study, 2021-2022.

Seroprevalence of Borrelia burgdorferi sensu lato antibodies in English adult blood donors: A nationwide cross-sectional study, 2021-2022.

Journal: Ticks and tick-borne diseases

Published: August 16, 2024

Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial.

Effect of a 2-week interruption in methotrexate treatment on COVID-19 vaccine response in people with immune-mediated inflammatory diseases (VROOM study): a randomised, open label, superiority trial.

Journal: The Lancet. Rheumatology

Published: October 05, 2023

Antibody correlates of protection against Delta infection after vaccination: A nested case-control within the UK-based SIREN study.

Antibody correlates of protection against Delta infection after vaccination: A nested case-control within the UK-based SIREN study.

Journal: The Journal of infection

Published: May 14, 2023

Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection.

Large clones of pre-existing T cells drive early immunity against SARS-COV-2 and LCMV infection.

Journal: iScience

Published: February 08, 2023

Monkeypox virus-infected individuals mount comparable humoral immune responses as Smallpox-vaccinated individuals.

Monkeypox virus-infected individuals mount comparable humoral immune responses as Smallpox-vaccinated individuals.

Journal: Nature communications

Published: January 12, 2023

The importance of using WHO International Standards to harmonise SARS-CoV-2 serological assays.

The importance of using WHO International Standards to harmonise SARS-CoV-2 serological assays.

Journal: The Lancet. Microbe

Published: December 16, 2022

Evaluating the use of the first WHO International Standard for anti-SARS-CoV-2 immunoglobulin to harmonise the readouts between commercial SARS-CoV-2 binding antibody tests: the HARMONY multicentre calibration study.

Evaluating the use of the first WHO International Standard for anti-SARS-CoV-2 immunoglobulin to harmonise the readouts between commercial SARS-CoV-2 binding antibody tests: the HARMONY multicentre calibration study.

Journal: The Lancet. Microbe

Published: December 15, 2022

Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity.

Persistent symptoms after COVID-19 are not associated with differential SARS-CoV-2 antibody or T cell immunity.

Journal: Nature communications

Published: November 30, 2022

Showing 1-12 of 238

Last Updated: 09/26/2026